Production (Stage)
eXoZymes, Inc.
EXOZ
$12.81
-$0.34-2.59%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 88.22% | 158.21% | 144.08% | 499.23% | 171.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 93.43% | 101.49% | 311.36% | 600.37% | 235.72% |
| Operating Income | -93.43% | -101.35% | -311.36% | -645.99% | -318.12% |
| Income Before Tax | -84.08% | -74.01% | -218.17% | -662.72% | -318.12% |
| Income Tax Expenses | -- | -104.96% | -- | -- | -- |
| Earnings from Continuing Operations | -84.08% | -67.12% | -218.17% | -663.90% | -318.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -84.08% | -67.12% | -218.17% | -663.90% | -318.12% |
| EBIT | -93.43% | -101.35% | -311.36% | -645.99% | -318.12% |
| EBITDA | -98.82% | -106.86% | -350.98% | -840.67% | -379.81% |
| EPS Basic | -37.48% | -39.25% | -218.01% | -663.51% | -318.13% |
| Normalized Basic EPS | -37.60% | -45.08% | -217.85% | -662.92% | -318.26% |
| EPS Diluted | -37.48% | -39.25% | -218.01% | -663.51% | -318.13% |
| Normalized Diluted EPS | -37.60% | -45.08% | -217.85% | -662.92% | -318.26% |
| Average Basic Shares Outstanding | 33.88% | 19.99% | 0.04% | 0.02% | 0.00% |
| Average Diluted Shares Outstanding | 33.88% | 19.99% | 0.04% | 0.02% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |